INTRODUCTION {#s1}
============

Rearrangement involving the *RET* proto-oncogene, referred to *RET/PTC* (the rearranged during transfection/papillary thyroid carcinoma tyrosine kinase) fusion genes, is one of the best-known mutations in papillary thyroid carcinoma (PTC) \[[@R1]\]. *RET/PTC* is identified as a specific genetic event in patients with PTC, which forms the basis of differential diagnosis and novel therapeutic approaches to this disease \[[@R2]\]. However, the prevalence rate of the major *RET/PTC* subtypes in different ethnicities and their correlation with the clinicopathologic features of PTC remains controversial and as yet are not routinely investigated in clinical practice.

The receptor tyrosine kinase RET plays a critical role in cell differentiation and proliferation, which is required for normal development of several tissues, especially in early embryogenesis \[[@R3]\]. In 1985, Takahashi and colleagues initially reported *RET* as a proto-oncogene that can be activated by interchromosomal rearrangement \[[@R4]\]. Subsequent studies demonstrated more than a dozen different forms of *RET* rearrangement, of which *RET/PTC1* and *RET/PTC3* are the most common, resulting from the fusion of *RET* with *H4* and of *RET* with *RFG/ELE1* respectively \[[@R5]\]. However, their prevalence rates in PTC exhibit significant geographic variation, ranging from 0% to 86.7% among studies \[[@R6], [@R7]\]. As risk factors such as sex, age, and radiation exposure are related to PTC pathogenesis, scientists have focused on searching for the factors that increase *RET/PTC*rearrangement risk. Accordingly, several studies have detected *RET/PTC* rearrangements more frequently in PTC in children than in adults \[[@R8], [@R9]\]. A relatively high prevalence of *RET/PTC* rearrangements was reported in radiation-induced PTC \[[@R10]\]. In addition, ethnicity and demographic characteristics may also influence the frequency of *RET/PTC* rearrangement \[[@R11]-[@R13]\]. To date, numerous relevant studies have been published but with divergent results.

In this study, we aimed to identify an enriched population who were more likely to occur RET/PTC1 and RET/PTC3 fusion genes and to provide more useful information on candidate selection for PTC prevention, diagnosis, and treatment. Therefore, we performed this meta-analysis to investigate the association between the presence/absence of *RET/PTC1* or *RET/PTC3* and radiation exposure, sex, age, and ethnicity.

RESULTS {#s2}
=======

Basic characteristics of enrolled studies {#s2_1}
-----------------------------------------

The article selection flowchart is depicted in Figure [1](#F1){ref-type="fig"}. A total 2014 records were obtained by searching the PubMed, Web of Science, and Embase databases. After removing duplicates, we found 1206 potentially relevant records. By reviewing titles, abstracts, and full texts according to the inclusion and exclusion criteria, 1168 articles were excluded because they were not relevant, involved in vitro or animal experiments, were reviews or meeting abstracts, contained data covered by other studies, had no raw data, etc. Eventually, 38 full-text articles, which consisted of 2395 PTC cases, met our inclusion criteria and were included in the final meta-analysis \[[@R6]-[@R10], [@R14]-[@R47]\].

![Flowchart of literature search and selection of studies](oncotarget-07-16716-g001){#F1}

The main characteristics of the studies included in this meta-analysis are summarized in Table [1](#T1){ref-type="table"}. The status of the *RET/PTC* fusion gene in the original studies were detected by PCR combined with reverse transcription (RT), Southern Blot or fluorescence in situ hybridization (FISH). The included studies involved populations from different geographical regions, namely Asia, Europe, and America; therefore, we divided the studies into Asian and Western subgroups.

###### Characteristics of studies included in the meta-analysis

  First author          Year of publication   Ethnicity                              Region    Method of detection     Radiation       No.of patients
  --------------------- --------------------- -------------------------------------- --------- ----------------------- --------------- ----------------
  Nikiforov et al       1997                  Belarussian, Los Angeles, Cincinnati   Western   RT-PCR                  Mixed           55
  Bounacer et al        1997                  French                                 Western   RT-PCR                  Mixed           39
  Motomura et al        1998                  Japanese                               Asian     RT-PCR                  Non-radiation   21
  Smida et al           1999                  Belarussian, German                    Western   RT-PCR                  Mixed           83
  Rabes et al           2000                  Belarus, Russia, Ukrainian             Western   PCR                     Radiation       191
  Elisei et al          2001                  Belarus, Itaian                        Western   PCR                     Mixed           89
  Puxeddu et al         2003                  Italian                                Western   RT-PCR, Southern Blot   Non-radiation   48
  Rhoden et al          2004                  American                               Western   RT-PCR                  NM              25
  Nakazawa et al        2005                  Japanese                               Asian     RT-PCR                  Non-radiation   169
  Brzezianska et al     2006                  Polish                                 Western   RT-PCR                  NM              33
  Hamatani et al        2008                  Japanese                               Asian     RT-PCR                  Mixed           71
  Tuttle et al          2008                  Russian                                Western   RT-PCR                  Radiation       76
  Lam et al             2002                  China, Hong Kong                       Asian     RT-PCR                  Non-radiation   21
  Detours et al         2005                  Ukrainian                              Western   RT-PCR                  Mixed           20
  Lima et al            2004                  Ukrainian                              Western   RT-PCR                  Mixed           34
  Penko et al           2005                  American                               Western   PCR                     Mixed           13
  Romei et al           2008                  Italian                                Western   RT-PCR                  Non-radiation   70
  Hieber et al          2011                  Ukrainian                              Western   FISH                    Radiation       22
  Guerra et al          2014                  Italian                                Western   RT-PCR                  NM              72
  Zou et al             2014                  Saudi Arabian                          Asian     RT-PCR                  NM              88
  Chung et al           1999                  Korean                                 Asian     RT-PCR                  Non-radiation   31
  Powell et al          2005                  Ukrainian                              Western   PCR                     Mixed           35
  Unger et al           2004                  Ukrainian                              Western   FISH                    Radiation       29
  Wang et al            2008                  Chinese                                Asian     RT-PCR                  Non-radiation   126
  Nikiforova et al      2004                  Belorussian, Ukrainian                 Western   PCR                     Mixed           137
  Basolo et al          2002                  Italian                                Western   RT-PCR                  NM              91
  Rao et al             2014                  Indian                                 Asian     RT-PCR                  Non-radiation   30
  Collins et al         2002                  American                               Western   IHC                     Mixed           64
  Chung et al           2004                  Korean                                 Asian     RT-PCR+IHC              Non-radiation   22
  Unger et al           2006                  Ukrainian                              Western   FISH                    Radiation       13
  Sadetzki et al        2004                  Israelis                               Asian     RT-PCR                  Mixed           49
  Smyth et al           2005                  Irish                                  Western   Taqman                  NM              34
  Learoyd et al         1998                  Australian, Swedish                    Western   RT-PCR                  Mixed           50
  Nakazawa et al        2009                  Japanese                               Asian     FISH+RT-PCR             Non-radiation   14
  Di Cristofaro et al   2005                  Ukrainian, French                      Western   RT-PCR                  Mixed           50
  Erdogan               2008                  Turkish                                Asian     RT-PCR                  Non-radiation   101
  Fenton et al          2000                  American                               Western   PCR                     Non-radiation   33
  Guerra et al          2011                  Italian                                Western   RT-PCR                  NM              50
  Stanojevic et al      2011                  Serbian                                Western   PCR                     Non-radiation   266

We also summarized the positive rates of *RET/PTC* from each original study (Table [2](#T2){ref-type="table"}). The overall prevalence of *RET/PTC* was relatively higher in the Western populations (42.19%) than in the Asian populations (36.73%). A similar tendency was observed for the *RET/PTC1* subtype, whereas the Asian populations demonstrated a higher positive rate for the *RET/PTC3* subtype (Asian vs. Western populations: 26.50% vs. 17.05%). In the Asian studies, the positive rates of *RET/PTC3* in the studies by Lam et al. \[[@R16]\] and Rao et al. \[[@R7]\] were up to 85.71% and 86.67%, respectively, while another six studies reported a much lower incidence of *RET/PTC3* that ranged from 0% to 20.79% \[[@R9], [@R14], [@R20]-[@R23]\].

###### Positive rates of *RET/PTC1* and *RET/PTC3* in each original study

  First author              Year of publication   No. of PTC cases   Freq. of RET/PTC1 and 3   RET/PTC1 and 3(%)   Freq. of RET/PTC1   RET/PTC1(%)   Freq. of RET/PTC3   RET/PTC3(%)
  ------------------------- --------------------- ------------------ ------------------------- ------------------- ------------------- ------------- ------------------- -------------
  **For Asian studies**                                                                        **36.73%**                              **21.06%**                        **26.50%**
  Motomura et al            1998                  21                 7                         33.33%              5                   23.81%        2                   9.52%
  Nakazawa et al            2005                  169                48                        28.40%              43                  25.44%        8                   4.73%
  Hamatani et al            2008                  71                 12                        16.90%                                                                    
  Lam et al                 2002                  21                 18                        85.71%                                                18                  85.71%
  Zou et al                 2014                  88                 12                        13.64%              12                  13.64%                            
  Chung et al               1999                  31                 4                         12.90%                                                                    
  Wang et al                2008                  126                18                        14.29%                                                                    
  Rao et al                 2014                  30                 26                        86.67%              0                   0.00%         26                  86.67%
  Chung et al               2004                  22                 2                         9.09%               1                   4.55%         1                   4.55%
  Sadetzki et al            2004                  49                 22                        44.90%              20                  40.82%        0                   0.00%
  Nakazawa et al            2009                  14                 4                         28.57%              4                   28.57%        0                   0.00%
  Erdogan                   2008                  101                67                        66.34%              32                  31.68%        21                  20.79%
  **For Western studies**                                                                      **42.19%**                              **25.25%**                        **17.05%**
  Nikiforov et al           1997                  55                 40                        72.73%              14                  25.45%        25                  45.45%
  Bounacer et al            1997                  39                 18                        46.15%              15                  38.46%        5                   12.82%
  Smida et al               1999                  83                 39                        46.99%              26                  31.33%        13                  15.66%
  Rabes et al               2000                  191                86                        45.03%              48                  25.13%        38                  19.90%
  Elisei et al              2001                  89                 40                        44.94%              18                  20.22%        26                  29.21%
  Puxeddu et al             2003                  48                 13                        27.08%              8                   16.67%        5                   10.42%
  Rhoden et al              2004                  25                 18                        72.00%              18                  72.00%        5                   20.00%
  Brzezianska et al         2006                  33                 7                         21.21%                                                                    
  Tuttle et al              2008                  76                 13                        17.11%              11                  14.47%        5                   6.58%
  Detours et al             2005                  20                 7                         35.00%              1                   5.00%         2                   10.00%
  Lima et al                2004                  34                 14                        41.18%                                                                    
  Penko et al               2005                  13                 7                         53.85%              5                   38.46%        2                   15.38%
  Romei et al               2008                                                                                   13                  18.57%        12                  17.14%
  Hieber et al              2011                  22                 17                        77.27%                                                                    
  Guerra et al              2014                  72                 12                        16.67%                                                                    
  Powell et al              2005                  35                 16                        45.71%                                                                    
  Unger et al               2004                  29                 5                         17.24%              2                   6.90%         3                   10.34%
  Nikiforova et al          2004                  137                48                        35.04%              16                  11.68%        32                  23.36%
  Basolo et al              2002                  91                 28                        30.77%              6                   6.59%         22                  24.18%
  Collins et al             2002                  64                 44                        68.75%                                                                    
  Unger et al               2006                  13                 10                        76.92%                                                                    
  Smyth et al               2005                  34                 13                        38.24%              10                  29.41%        3                   8.82%
  Learoyd et al             1998                  50                 4                         8.00%               4                   8.00%         0                   0.00%
  Di Cristofaro et al       2005                  50                 30                        60.00%              26                  52.00%        13                  26.00%
  Fenton et al              2000                  33                 14                        42.42%              11                  33.33%        3                   9.09%
  Guerra et al              2011                  50                 18                        36.00%                                                                    
  Stanojevic et al          2011                  266                55                        20.68%              42                  15.79%        13                  4.89%

Association between radiation exposure and RET/PTC fusion genes {#s2_2}
---------------------------------------------------------------

As radiation exposure is the best-known risk factor for PTC, we initially investigated the effect of radiation on *RET/PTC* rearrangement (Table [3](#T3){ref-type="table"}). Fourteen studies investigated the distribution difference of radiation exposure between *RET/PTC*-positive and -negative patients with PTC. When the *RET/PTC1* and *RET/PTC3* subtypes were combined, radiation exposure conferred increased overall risk for *RET/PTC* development (OR = 2.82, 95%CI: 1.38--5.78; P = 0.005, Figure [2](#F2){ref-type="fig"}) and there was moderate heterogeneity (I^2^ = 74%, P~het~ \< 0.001). Stratified analysis according to geographical region decreased the heterogeneity slightly, and increased risk for *RET/PTC* rearrangement persisted in the Western subpopulation, demonstrating an increased OR of 3.97 (95%CI: 2.03--7.75; P \< 0.001).

###### Meta-analysis results for association between *RET/PTC* fusion genes and radiation exposure in patients with PTC

  Radiation exposure vs. non-radiation exposure   No. of studies   No. of cases/controls   OR(95%CI)              P value       Model    I^2^     Phet[^a^](#tfn_001){ref-type="table-fn"}
  ----------------------------------------------- ---------------- ----------------------- ---------------------- ------------- -------- -------- ------------------------------------------
  **For RET/PTC1 and 3**                                                                                                                          
   All                                            14               537/388                 **2.82(1.38,5.78)**    **0.005**     Random   74%      \<0.001
   Region                                                                                                                                         
   Asian                                          4                232/71                  0.88(0.26,2.93)        0.833         Random   56%      0.077
   Western                                        10               305/317                 **3.97(2.03,7.75)**    **\<0.001**   Random   59%      \<0.001
  **For RET/PTC1**                                                                                                                                
   All                                            9                285/287                 1.86(0.66, 5.28)       0.243         Random   76.00%   \<0.001
   Region                                                                                                                                         
   Asian                                          1                37/12                   0.24(0.06,0.96)        0.043         Random   /        /
   Western                                        8                248/275                 2.46(0.83,7.27)        0.104         Random   74.10%   \<0.001
  **For RET/PTC3**                                                                                                                                
   All[^b^](#tfn_002){ref-type="table-fn"}        8                243/240                 **8.30(4.32,15.96)**   **\<0.001**   Fixed    0.00%    0.980
   Region                                                                                                                                         
   Asian                                          /                /                       /                      /             /        /        /
   Western                                        8                243/240                 **8.30(4.32,15.96)**   **\<0.001**   Fixed    0.00%    0.980

P-value for heterogeneity test;

Data from Sadetzki et al. \[[@R21]\] and Learoyd et al. \[[@R6]\] showed that the *RET/PTC3* gene prevalence was 100% in both the groups with and without radiation exposure and that the OR and standard error could not be estimated; therefore, these studies were excluded. The statistically significant results are highlighted in bold.

![Results of the association between *RET/PTC1* and *RET/PTC3* fusion genes and radiation exposure in patients with PTC](oncotarget-07-16716-g002){#F2}

When the *RET/PTC1* and *RET/PTC3* subtypes were considered separately, radiation exposure conferred significantly higher risk for *RET/PTC3* rearrangement (OR = 8.30, 95%CI: 4.32--15.96; P \< 0.001, Figure [3](#F3){ref-type="fig"}) but not for *RET/PTC1* rearrangement. This association was only evident in the Western subpopulation. Separate pooled analysis for the *RET/PTC1* and *RET/PTC3* subtypes was not performed for the Asian subpopulation because three original studies involving this population investigated the combined status of *RET/PTC1* and *RET/PTC3*, and the data could not be extracted separately \[[@R9], [@R15], [@R22]\]. Only one study with a small sample in an Asian country reported the *RET/PTC1* and *RET/PTC3* fusion gene data separately \[[@R21]\]. There was significant inter-study heterogeneity in the *RET/PTC1* analysis but not in the *RET/PTC3* analysis.

![Results of the association between *RET/PTC3* fusion gene and radiation exposure in patients with PTC](oncotarget-07-16716-g003){#F3}

Association between RET/PTC fusion genes and age {#s2_3}
------------------------------------------------

Different age effects have been observed in the development of PTC, and we therefore explored whether young age affected the penetrance of the*RET/PTC* fusion genes in children and adolescents (Table [4](#T4){ref-type="table"}). In this meta-analysis, age \< 18 years was considered young, i.e., children and adolescents. In the combined analysis of the *RET/PTC1* and *RET/PTC3* subtypes, no association was observed between age and *RET/PTC* rearrangement. In the separate analysis of the *RET/PTC1* and *RET/PTC3* subtypes, young people had nearly two-fold greater risk for *RET/PTC3* rearrangement (Figure [4](#F4){ref-type="fig"}) but penetrance of the *RET/PTC1* fusion gene was not affected. When radiation exposure was also considered, young people in the subpopulation with radiation exposure had higher risk for developing *RET/PTC3* rearrangement as compared to adults with radiation exposure. These positive associations were performed in a fixed-effects model and had slight inter-study heterogeneity (all Phet \> 0.10).

###### Meta-analysis results for association between *RET/PTC* fusion genes and age in patients with PTC

  Young people vs. adult    No. of studies   No. of cases/controls   OR(95%CI)             P value     Model    I^2^     Phet[^a^](#tfn_003){ref-type="table-fn"}
  ------------------------- ---------------- ----------------------- --------------------- ----------- -------- -------- ------------------------------------------
  **For RET/PTC1 and 3**                                                                                                 
   All                      8                187/332                 1.10(0.56,2.16)       0.783       Random   51.50%   0.044
   Region                                                                                                                
   Asian                    2                41/149                  1.76(0.84,3.69)       0.133       Fixed    4.30%    0.307
   Western                  6                146/183                 0.98(0.41,2.31)       0.956       Random   54.50%   0.052
   Radiation                                                                                                             
   Radiation exposure       6                116/122                 0.88(0.48,1.62)       0.682       Fixed    41.50%   0.129
   Non-radiation exposure   5                71/200                  1.46(0.81,2.65)       0.212       Fixed    33.90%   0.195
  **For RET/PTC1**                                                                                                       
   All                      6                172/286                 0.98(0.60,1.58)       0.921       Fixed    7.20%    0.370
   Region                                                                                                                
   Asian                    2                41/149                  1.33(0.61,2.91)       0.476       Fixed    0.00%    0.466
   Western                  4                131/137                 0.81(0.44,1.50)       0.507       Fixed    21.40%   0.282
   Radiation                                                                                                             
   Radiation exposure       5                107/109                 0.52(0.26,1.05)       0.070       Fixed    49.30%   0.096
   Non-radiation exposure   5                71/200                  1.47(0.76,2.86)       0.250       Fixed    0.00%    0.574
  **For RET/PTC3**                                                                                                       
   All                      7                179/318                 **2.03(1.14,3.62)**   **0.017**   Fixed    46.70%   0.081
   Region                                                                                                                
   Asian                    2                42/148                  3.23(0.87,12.00)      0.080       Fixed    7.20%    0.299
   Western                  5                137/170                 1.84(0.97,3.50)       0.206       Random   50.1%%   0.091
   Radiation                                                                                                             
   Radiation exposure       5                107/109                 **2.35(1.01,5.49)**   **0.048**   Fixed    0.00%    0.574
   Non-radiation exposure   5                72/199                  1.68(0.28,10.01)      0.570       Random   67.00%   0.028

P-value for heterogeneity test. The statistically significant results are highlighted in bold.

![Results of the association between *RET/PTC3* fusion gene and young age in patients with PTC](oncotarget-07-16716-g004){#F4}

Association between RET/PTC fusion genes and sex {#s2_4}
------------------------------------------------

Females are more likely to develop PTC, therefore we investigated whether female gender increases the chance of *RET/PTC* rearrangement in patients with PTC. As suggested by the findings in Table [5](#T5){ref-type="table"}, sex was not statistically associated with *RET/PTC* status in the combined analysis. In subgroup analysis, a pooled analysis of 13 studies showed that female gender was associated with *RET/PTC1* development in the subpopulation without radiation exposure. Female patients had 1.69-fold greater risk for *RET/PTC1* rearrangement than male patients did (95%CI: 1.04--2.74; P = 0.034, Figure [5](#F5){ref-type="fig"}). However, female gender did not appear to play a role in *RET/PTC3* rearrangement (all, P \> 0.05). Only slight inter-study heterogeneity was observed in all of the above analyses (all Phet \> 0.10).

###### Meta-analysis results for association between *RET/PTC* fusion genes and sex in patients with PTC

  Female vs. male            No. of studies   No. of cases/controls   OR(95%CI)             P value     Model   I2      Phet[^a^](#tfn_004){ref-type="table-fn"}
  -------------------------- ---------------- ----------------------- --------------------- ----------- ------- ------- ------------------------------------------
  **For RET/PTC1 and 3**                                                                                                
    All                      27               1211/474                1.04(0.81,1.33)       0.775       Fixed   0.00%   0.938
    Region                                                                                                              
    Asian                    9                373/138                 1.42(0.81,2.49)       0.216       Fixed   0.00%   0.754
    Western                  18               838/336                 0.95(0.72,1.27)       0.747       Fixed   0.00%   0.934
    Radiation                                                                                                           
    Radiation exposure       11               369/174                 0.94(0.63,1.41)       0.760       Fixed   0.00%   0.941
    Non-radiation exposure   17               721/258                 1.28(0.90,1.82)       0.171       Fixed   7.20%   0.370
  **For RET/PTC1**                                                                                                      
    All a                    16               832/324                 1.21(0.87,1.69)       0.256       Fixed   0.00%   0.857
    Region                                                                                                              
    Asian                    5                213/62                  0.98(0.48,2.01)       0.962       Fixed   0.00%   0.604
    Western                  11               619/261                 1.28(0.88,1.87)       0.193       Fixed   0.00%   0.796
    Radiation                                                                                                           
    Radiation exposure       4                185/104                 1.22(0.70,2.11)       0.482       Fixed   0.00%   0.892
    Non-radiation exposure   13               581/192                 **1.69(1.04,2.74)**   **0.034**   Fixed   0.00%   0.768
  **For RET/PTC3**                                                                                                      
    All,b                    17               785/304                 0.87(0.60,1.27)       0.466       Fixed   0.00%   0.625
    Region                                                                                                              
    Asian                    5                155/40                  1.54(0.59,3.99)       0.378       Fixed   0.00%   0.763
    Western                  11               619/261                 0.77(0.51,1.17)       0.223       Fixed   0.00%   0.527
    Radiation                                                                                                           
    Radiation exposure       4                185/104                 0.82(0.45,1.48)       0.504       Fixed   0.00%   0.903
    Non-radiation exposure   11               570/186                 1.06(0.60,1.87)       0.847       Fixed   0.00%   0.696

P-value for heterogeneity test;

Data from Rao et al. \[[@R7]\] and Detours et al. \[[@R31]\] showed that *RET/PTC1* gene prevalence was 100% in both female and male groups and that the OR and standard error could not be estimated; therefore, these studies were excluded. The statistically significant results are highlighted in bold.

![Results of the association between *RET/PTC1* fusion gene and female gender in PTC patients without radiation exposure](oncotarget-07-16716-g005){#F5}

Heterogeneity testing and sensitivity analysis {#s2_5}
----------------------------------------------

The inter-study heterogeneities in each comparison are presented in Tables [3](#T3){ref-type="table"}--[5](#T5){ref-type="table"}. Pooled analyses for assessing the effect of radiation exposure and young age on the combined status of the *RET/PTC1* and *RET/PTC3* fusion genes demonstrated moderate heterogeneity. To explore the source of heterogeneity, subgroup analyses based on ethnicity and *RET/PTC* subtype were performed. Heterogeneity was decreased in the subgroup analysis and may be partly explained by the different ethnicities and *RET/PTC* subtypes (Tables [3](#T3){ref-type="table"} and [5](#T5){ref-type="table"}).

Sensitivity analysis was also conducted to assess the influence of individual studies on the overall risk of *RET/PTC* rearrangement by excluding any single study in turn and recalculating the pooled ORs and 95%CI. For the effect of radiation on *RET/PTC* rearrangement, Sadetzki et al. \[[@R21]\], Nakazawa et al. \[[@R22]\], and Bounacer et al. \[[@R24]\] reported greater differences in the risk estimates compared with other studies in the sensitivity analysis. Sensitivity analysis excluding the three studies generated a similar pooled OR of 3.30 (95%CI: 1.96--5.54, P \< 0.001; I^2^= 32.1%, P~het~ = 0.142) among homogeneous studies. For the effect of young age on *RET/PTC* rearrangement, the outlier studies appeared to be the studies of Smida et al. (1999)\[[@R8]\] and Hieber et al. (2011)\[[@R35]\]. After removing the two studies, the heterogeneity was no longer significant (I^2^= 34.0%, P~het~ = 0.181), and similar estimates (OR = 1.10 vs. 1.53) were generated before and after these data were removed, indicating the relatively high stability of the results.

Publication bias {#s2_6}
----------------

Begg\'s test and Egger\'s test were performed to quantitatively evaluate the publication bias of the studies; the results are listed in Table [6](#T6){ref-type="table"}. No significant publication bias was observed in all comparisons (all, P \> 0.10).

###### Analysis for publication bias

  Variable                                          Begg\'s test   Egger\'s test           
  ------------------------------------------------- -------------- --------------- ------- -------
  **For RET/PTC1 and 3**                                                                   
    Radiation exposure vs. non-radiation exposure   0.93           0.352           1.34    0.205
    Female vs. male                                 1.02           0.307           0.24    0.811
    Children and adolecent vs. adult                −0.25          0.805           0.16    0.882
  **For RET/PTC1**                                                                         
    Radiation exposure vs. non-radiation exposure   1.25           0.211           1.71    0.132
    Female vs. male                                 0.27           0.787           0.15    0.879
    Children and adolecent vs. adult                −0.19          0.851           0.39    0.715
  **For RET/PTC3**                                                                         
    Radiation exposure vs. non-radiation exposure   −0.56          0.573           −1.75   0.156
    Female vs. male                                 0.27           0.787           0.59    0.567
    Children and adolecent vs. adult                0.45           0.652           1.92    0.113

P value\>0.1 was considered as no publication bias.

DISCUSSION {#s3}
==========

Previous study results on the relationship between PTC-related risk factors and *RET/PTC* rearrangement were controversial. To our knowledge, this is the first meta-analysis evaluating the effect of radiation exposure, female gender, and young age on *RET/PTC* rearrangement. By performing the present meta-analysis, we found that radiation exposure contributed to increased risk of *RET/PTC* rearrangement, especially for the *RET/PTC3* subtype. Young age was also associated with higher prevalence of *RET/PTC3*, and this association was more significant in the subpopulation exposed to radiation. Our pooled estimate also demonstrated an association between female gender and higher prevalence of the *RET/PTC1* subtype in the subpopulation that had not been exposed to radiation. These results identify an enriched population of RET/PTC fusion genes in patients with PTC and provide novel insights into the utility of RET/PTC rearrangement in the differential diagnosis of suspicious PTC.

Exposure to ionizing radiation is a well-known risk factor for thyroid cancer, particularly for papillary carcinoma \[[@R48], [@R49]\]. Therefore, it is likely that radiation exposure may also be a causative factor for *RET/PTC* rearrangement. Our pooled estimates provide clear evidence that radiation exposure could be responsible for the difference in *RET/PTC3* prevalence between sporadic and radiation-associated tumors, whereas the rate of *RET/PTC1* prevalence was similar between the two groups. The corresponding pooled OR for *RET/PTC3* was up to 8.30, and this association was evident in the Western populations. However, we could not derive a negative or null association in the Asian population because of a lack of original studies from the Asian region. There are valid reasons to believe that there is a causative link between radiation exposure and *RET/PTC* rearrangements. For example, Nikiforov et al. reported much higher *RET/PTC3* prevalence in post-Chernobyl PTC than in subjects without radiation exposure \[[@R10]\]. In addition, *RET/PTC* rearrangement, predominantly *RET/PTC3*, in thyroid cells, can be induced by ionizing radiation \[[@R50]\]. This may be linked to the particular effectiveness of radiation in causing double-strand breaks, which would be the direct cause of RET rearrangement \[[@R50], [@R51]\]. This mechanism may partially explain the association between radiation exposure and *RET/PTC* rearrangement in thyroid cancer.

The data synthesis in the present meta-analysis also demonstrated increased risk of *RET/PTC3* in PTC in young people. Our observations further indicate that young patients who exposed to radiation have higher *RET/PTC3* risk than young patients who have not been exposed to radiation. Original studies have shown that *RET/PTC3* is more common in children and adolescents compared to adults \[[@R8], [@R9]\]. When the radiation exposure effect was considered in young people, *RET/PTC3* was indicated as the most common form of rearrangement in radiation-associated childhood PTC \[[@R8], [@R10], [@R25], [@R52]\]. As the thyroid is very sensitive to radiation, the thyroid of young people might be more vulnerable to radiation than that of adults, which may result in higher *RET/PTC* prevalence in young people \[[@R53]\]. Nevertheless, it is important to consider that the statistical power in each original study may be partly determined by the cutoff value of age, such as age at diagnosis and age at exposure to radiation. When the cutoff age varies, the issue of the impact of patient age on *RET/PTC* rearrangement remains inconclusive, which would require further validation. By setting a cutoff age of 18 years in this meta-analysis, the corresponding results may indicate the relatively low defense ability of children against pathogenic factors.

Concerning the impact of sex, we observed that the association between female gender and increased *RET/PTC1* risk was more significant in patients who had not been exposed to radiation. For unknown reasons, thyroid cancer is three times more prevalent in women than in men \[[@R54]\]. One possible explanation for this gender disparity is the hormonal differences between men and women. It has been documented that chromosome breaks and sister chromatid exchanges are elevated in women who are pregnant or taking oral contraceptives \[[@R55]\]. There is also evidence supporting the premise that *RET/PTC* is an estrogen-dependent gene required for breast cancer cell growth \[[@R56]\]. The above evidence suggests that some inherent differences render females more susceptible to *RET* rearrangements.

Nevertheless, this study has some limitations. First, although we included all available relevant articles in this meta-analysis, the sample sizes remain insufficiently large. Second, most studies in relation to the association between radiation exposure and *RET/PTC3* were from the Western countries, thus the generalizability of our conclusions is limited. In the future, more studies are needed to confirm this association in Asian regions. Third, only two common *RET/PTC* subtypes, *RET/PTC1* and *RET/PTC3*, were considered in this study, mainly due to the limitation of current laboratory techniques for simultaneously detecting all *RET/PTC* subtypes.

In conclusion, both radiation exposure and young age, i.e., age \< 18 years, are associated with increased risk of *RET/PTC3* rearrangement. In addition, female gender is associated with higher prevalence of the *RET/PTC1* subtype in the subpopulation not exposed to radiation. We suggest that *RET/PTC* status in combination with radiation exposure, age, and sex should be considered when differential diagnoses are suggested for suspicious patients. Further large-scale studies concerning the relationship between radiation exposure and *RET/PTC* in the Asian population are required to confirm our meta-analysis results.

MATERIALS AND METHODS {#s4}
=====================

Search strategy {#s4_1}
---------------

We searched the PubMed, Web of Science, and Embase databases for all articles on the association between the *RET/PTC* fusion gene and PTC up to June 2015. The published date of available articles in this study was from 1959 to 2015. The keywords used for the search were "*RET/PTC*", "*RET/PTC* fusion gene", or "*RET/PTC* fusion oncoproteins" in combination with "Thyroid Cancer", "Thyroid Carcinoma", "Thyroid Neoplasms", or "Thyroid Papillary Carcinoma". The references of the articles acquired were also searched manually to broaden the search. When there was overlapping data, only the largest and most recent study was selected for this meta-analysis. If the data presented in an article were unclear, we contacted the author for specific raw data.

Inclusion and exclusion criteria {#s4_2}
--------------------------------

Eligible studies had to meet the following criteria: (1) the association between the *RET/PTC* fusion gene and the clinicopathological features of patients with PTC was explored; (2) PTC diagnosis was made according to the pathology results; (3) studies were full-text articles; and (4) there was sufficient data for estimating an odds ratio (OR) with a 95% confidence interval (CI). The exclusion criteria were: (1) duplicate publication; (2) article was an abstract, comment, review, conference proceeding, or editorial; (3) insufficient data were reported; and (4) study was not in English or Chinese.

Data extraction {#s4_3}
---------------

The following items were collected: first name of first author; year of publication; population of study; number of enrolled patients; frequency of *RET/PTC* fusion gene; detection method; whether study subjects were children or adults; and clinicopathological features (sex, age, radiation history, and ethnicity). The above information was carefully extracted by two independent investigators (Xuan Su and Zhaoqu Li). If the two investigators could not reach a consensus, the result was reviewed by a third investigator (Caiyun He).

Statistical analyses {#s4_4}
--------------------

The strength of the association between *RET/PTC* and radiation exposure, age, and sex was estimated by OR and 95%CI. Two-sided P-values were evaluated in this meta-analysis, and P \< 0.05 was considered statistically significant. The chi-square--based Q test and I^2^ statistic were used to assess the statistical heterogeneity among studies. For the Q statistic, P \< 0.10 was considered statistically significant for heterogeneity. When there was heterogeneity, a random-effects model based on the DerSimonian and Laird method was used to calculate the pooled OR of each study \[[@R57]\]; otherwise, a fixed-effects model based on the Mantel--Haenszel method was used \[[@R58]\]. Publication bias was examined using Begg\'s and Egger\'s tests \[[@R59], [@R60]\], where P \< 0.10 was considered statistically significant. All analyses were performed using STATA 12.0. All tests were two-sided and the significance level was set at 0.05.
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